L'inhibition de l'activité transcriptionnelle de PRDM6 diminue la migration et l'invasion de cellules de cancer ovarien épithélial

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary ovarian cancer

  2026cited by this paper
• Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients

  2014cited by this paper
• The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review

  2013cited by this paper
• Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression

  2013cited by this paper
• DNA methyltransferases, DNA damage repair, and cancer.

  2013cited by this paper
• DNA hypomethylation and hemimethylation in cancer.

  2013influential reference
• Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

  2013influential reference
• Protein biomarkers of ovarian cancer: the forest and the trees.

  2012cited by this paper
• Nanocarrier systems for delivery of siRNA to ovarian cancer tissues

  2012cited by this paper
• Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs.

  2012influential reference
• REPRINTS AND REFLECTIONS

  2012cited by this paper
• Genomic imprinting: recognition and marking of imprinted loci.

  2012cited by this paper
• DNA methylation profiling in the clinic: applications and challenges

  2012cited by this paper
• Ovarian Cancer Incidence: Current and Comprehensive Statistics

  2012cited by this paper
• What lies behind chemotherapy-induced ovarian toxicity?

  2012cited by this paper
• The Quest for Ovarian Cancer Screening Biomarkers: Are We on the Right Road?

  2012cited by this paper
• DNA methylation in stem cell renewal and multipotency

  2011cited by this paper
• Epigenetic mechanisms and cancer: An interface between the environment and the genome

  2011cited by this paper
• The role of DNA methylation in mammalian development.

  2011cited by this paper
• Translational application of epigenetic alterations: Ovarian cancer as a model

  2011influential reference
• Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

  2011cited by this paper
• Long non-coding RNA modifies chromatin

  2011cited by this paper
• Drug therapy of cancer

  2011cited by this paper
• Regulation of chromatin by histone modifications

  2011cited by this paper
• DNA methylation and cancer: ghosts and angels above the genes

  2011cited by this paper
• The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Ovarian cancer development and metastasis.

  2010cited by this paper
• Transcriptional control of gene expression by microRNAs.

  2010cited by this paper
• Introduction: epigenetics and cancer.

  2010cited by this paper
• Phase II biomarker trial of a multimarker diagnostic for ovarian cancer

  2010cited by this paper
• The biology of ovarian cancer: new opportunities for translation

  2009cited by this paper
• Optimal Management of Recurrent Ovarian Cancer

  2009cited by this paper
• Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management

  2009cited by this paper
• Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer

  2009cited by this paper
• Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling.

  2009cited by this paper
• Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

  2008cited by this paper
• Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

  2008cited by this paper
• Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications

  2008cited by this paper
• Histologic subtypes of ovarian carcinoma: an overview.

  2008cited by this paper
• Infertility as a cancer risk factor - a review.

  2008cited by this paper
• Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

  2007cited by this paper
• Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

  2007cited by this paper
• Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies

  2007cited by this paper
• Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

  2007influential reference
• Development of an ovarian cancer symptom index: possibilities for earlier detection.

  2007cited by this paper
• KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.

  2006influential reference
• Genomic DNA methylation: the mark and its mediators.

  2006cited by this paper
• The epigenetic progenitor origin of human cancer

  2006influential reference
• Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex.

  2006cited by this paper
• Cancer-linked DNA hypomethylation and its relationship to hypermethylation.

  2006cited by this paper
• PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.

  2006cited by this paper
• Benign Epithelial Ovarian Tumours—cancer Precursors or Markers for Ovarian Cancer Risk?

  2006cited by this paper
• Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

  2005cited by this paper
• Fruits and Vegetables and Ovarian Cancer Risk in a Pooled Analysis of 12 Cohort Studies

  2005cited by this paper
• Chromatin remodeling in dosage compensation.

  2005cited by this paper
• Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

  2004cited by this paper
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

  2004influential reference
• DNA Hypomethylation and Ovarian Cancer Biology

  2004cited by this paper
• Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue

  2004cited by this paper
• Epigenetics in human disease and prospects for epigenetic therapy

  2004influential reference
• Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

  2003influential reference
• p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

  2003cited by this paper
• The nuclear RNase III Drosha initiates microRNA processing

  2003cited by this paper
• Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study.

  2003cited by this paper
• Ovarian cancer: strategies for overcoming resistance to chemotherapy

  2003cited by this paper
• Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

  2003cited by this paper
• Pathology and classification of ovarian tumors

  2003influential reference
• The fundamental role of epigenetic events in cancer

  2002influential reference
• Locus-specific control of asymmetric and CpNpG methylation by the DRM and CMT3 methyltransferase genes

  2002cited by this paper
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

  2002cited by this paper
• Epigenetic Reprogramming in Mammalian Development

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA

  2001cited by this paper
• p53 mutation is infrequent in clear cell carcinoma of the ovary.

  2001cited by this paper
• Symptoms of Ovarian Cancer

  2001cited by this paper
• Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer.

  2000cited by this paper
• Grading of Ovarian Carcinomas

  2000cited by this paper
• Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.

  1999cited by this paper
• K‐ras mutations in mucinous ovarian tumors

  1997cited by this paper
• Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

  1997cited by this paper
• Characteristics relating to ovarian cancer risk: implications for prevention and detection.

  1994cited by this paper
• The dam and dcm strains of Escherichia coli--a review.

  1994cited by this paper
• Cancer of the ovary.

  1993influential reference
• Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.

  1993cited by this paper
• Prader-Willi syndrome

  1989cited by this paper
• DNA methylation in the fungi.

  1984cited by this paper
• Hypomethylation distinguishes genes of some human cancers from their normal counterparts

  1983cited by this paper
• The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.

  1979cited by this paper
• Cellular and Molecular Life Sciences the Role of Genetics in the Establishment and Maintenance of the Epigenome

  year unknowncited by this paper

• No citing papers are available for this paper.